From Molecule to Market: Accelerating the Future of Pharma Commercialization

Session details:

The journey from drug discovery to patient impact is being transformed by data, technology, and AI — yet commercialization often lags behind. Join Chris Paquette, CEO of DeepIntent, as he shares a vision for uniting payers, providers, and patients through real-time intelligence, breaking down silos to deliver faster, more effective go-to-market strategies. Discover how AI and innovative, open technology can streamline commercialization, boost prescriber engagement and patient demand, and accelerate the delivery of life-changing treatments.